하지불안증후군 진단과 치료의 최신 지견
Updates on the Diagnosis and Treatment of Restless Legs Syndrome
2
조회
0
다운로드
4
인용
0
참고문헌
초록
Restless legs syndrome (RLS) is a neurological sleep disorder characterized by an urge to move the legs or arms and is associated with discomfort and paresthesia in the legs. RLS is diagnosed based on the clinical symptoms, and polysomnography is performed to quantify the periodic limb movements during sleep or in patients who undergo the suggested immobilization test. Determining the cause of RLS is important for accurately diagnosing and evaluating this condition. The treatment of RLS varies according to the etiology, severity, and frequency of the patients’ symptoms. Accurate identification and treatment of the cause of RLS are important in patients with secondary RLS. Iron supplementation could be useful in patients with uremia, iron deficiency, and for RLS during pregnancy. Dopamine agonists have been used as the first-line treatment for primary RLS. On the other hand, augmentation is a known adverse effect associated with the long-term use of dopamine agonists. Therefore, recent treatment guidelines recommend the administration of anticonvulsants, such as pregabalin and gabapentin, to treat RLS. Iron, opioids, or benzodiazepines may be useful in patients refractory to anticonvulsants or dopamine agonists. RLS is a chronic condition. Therefore, it is essential to establish a long-term treatment plan, considering both the efficacy and adverse effects of therapeutic agents used in patients.
Abstract
Restless legs syndrome (RLS) is a neurological sleep disorder characterized by an urge to move the legs or arms and is associated with discomfort and paresthesia in the legs. RLS is diagnosed based on the clinical symptoms, and polysomnography is performed to quantify the periodic limb movements during sleep or in patients who undergo the suggested immobilization test. Determining the cause of RLS is important for accurately diagnosing and evaluating this condition. The treatment of RLS varies according to the etiology, severity, and frequency of the patients’ symptoms. Accurate identification and treatment of the cause of RLS are important in patients with secondary RLS. Iron supplementation could be useful in patients with uremia, iron deficiency, and for RLS during pregnancy. Dopamine agonists have been used as the first-line treatment for primary RLS. On the other hand, augmentation is a known adverse effect associated with the long-term use of dopamine agonists. Therefore, recent treatment guidelines recommend the administration of anticonvulsants, such as pregabalin and gabapentin, to treat RLS. Iron, opioids, or benzodiazepines may be useful in patients refractory to anticonvulsants or dopamine agonists. RLS is a chronic condition. Therefore, it is essential to establish a long-term treatment plan, considering both the efficacy and adverse effects of therapeutic agents used in patients.
참고문헌 (47)
- Willis T., "De Animae Brutorum", Wells and Scott
- Ekbom KA, "Restless legs" (1945), Ivar Haeggströms
- Michaud M, "Arm restlessness in patients with restless legs syndrome", Mov Disord, 15, pp.289~293 (2000)
- Allen RP, "Restless legs syndrome", Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance, 2014, pp.15, 860~873
- Allen RP, "Principles and practice of sleep medicine", pp.923~934 (2017), Elsevier
- Phillips B, "Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll", Chest, 129, pp.76~80 (2006)
- Cho YW, "Epidemiology of restless legs syndrome in Korean adults", Sleep, 31, pp.219~223 (2008)
- Allen RP, "Restless legs syndrome prevalence and impact: REST general population study", Arch Intern Med, 165, pp.1286~1292 (2005)
- Ulfberg J, "Prevalence of restless legs syndrome among men aged 18 to 64 years : an association with somatic disease and neuropsychiatric symptoms", Mov Disord, 16, pp.1159~1163 (2001)
- Winkelman JW, "Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study", Neurology, 70, pp.35~42 (2008)
- In Cheol Hwang, "Higher Prevalence of Hypertension among Individuals with Restless Legs Syndrome: A Meta-Analysis", PSYCHIATRY INVESTIGATION, 15(7), pp.701~709 (2018), 대한신경정신의학회[DOI]
- Kurlan R, "Augmentation in restless legs syndrome: poor response to sudden withdrawal of dopaminergic therapy", J Parkinsonism Restless Legs Syndr, 3, pp.49~52 (2013)
- Allen RP, "Comparison of pregabalin with pramipexole for restless legs syndrome", N Engl J Med, 370, pp.621~631 (2014)
- Winkelman JW, "Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology", Neurology, 87, pp.2585~2593 (2016)
- Garcia-Borreguero D, "Guidelines for the first-line treatment of restless legs syndrome", Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation, 2016, pp.21, 1~11
- American Academy of Sleep Medicine, "International classification of sleep disorders" (2014), American Academy of Sleep Medicine
- American Psychiatry Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychaitry Association
- Allen RP, "The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia", Am J Hematol, 88, pp.261~264 (2013)
- Sloand JA, "A doubleblind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome", Am J Kidney Dis, 43, pp.663~670 (2004)
- Winkelmann J, "Long-term course of restless legs syndrome in dialysis patients after kidney transplantation", Mov Disord, 17, pp.1072~1076 (2002)
- Cho YW, "Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy: comparison with chronic osteoarthritis", Sleep Med, 14, pp.1387~1392 (2013)
- Lee HB, "Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community", J Neuropsychiatry Clin Neurosci, 20, pp.101~105 (2008)
- Rios Romenets S, "Restless legs syndrome outside the bloodbrain barrier--exacerbation by domperidone in Parkinson’s disease", Parkinsonism Relat Disord, 19, pp.92~94 (2013)
- Kang SG, "Characteristics and clinical correlates of restless legs syndrome in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1078~1083 (2007)
- Aggarwal S, "Restless leg syndrome associated with atypical antipsychotics: current status, pathophysiology, and clinical implications", Curr Drug Saf, 10, pp.98~105 (2015)
- Trotti LM, "Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis", Sleep Med, 10, pp.668~671 (2009)
- Haba-Rubio J, "Test-to-test variability in motor activity during the suggested immobilization test in restless legs patients", Sleep Med, 7, pp.561~566 (2006)
- Iber C, "The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification" (2007), American Academy of Sleep Medicine
- Fahn S, "Myoclonus: advances in neurology" (1986), Raven Press
- Pennestri MH, "PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution", Sleep, 29, pp.1183~1187 (2006)
- Karadeniz D, "Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients?", Eur J Neurol, 7, pp.331~336 (2000)
- Nicolas A, "Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category?", Eur Neurol, 40, pp.22~26 (1998)
- Michaud M, "Sleep laboratory diagnosis of restless legs syndrome", Eur Neurol, 48, pp.108~113 (2002)
- Lettieri CJ, "Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial", Chest, 135, pp.74~80 (2009)
- Mitchell UH, "Restless legs syndrome and near-infrared light: an alternative treatment option", Physiother Theory Pract, 27, pp.345~351 (2011)
- Koo YS, "Transcranial direct current stimulation on primary sensorimotor area has no effect in patients with drug-naïve restless legs syndrome: a proofof-concept clinical trial", Sleep Med, 16, pp.280~287 (2015)
- Bogan RK, "Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study", Mayo Clin Proc, 85, pp.512~521 (2010)
- Adler CH, "Treatment of restless legs syndrome with gabapentin", Clin Neuropharmacol, 20, pp.148~151 (1997)
- Mellick GA, "Management of restless legs syndrome with gabapentin (Neurontin)", Sleep, 19, pp.224~226 (1996)
- Garcia-Borreguero D, "Treatment of restless legs syndrome with gabapentin:a double-blind, cross-over study", Neurology, 59, pp.1573~1579 (2002)
- Montplaisir J, "Restless legs syndrome improved by pramipexole: a double-blind randomized trial", Neurology, 52, pp.938~943 (1999)
- Winkelman JW, "Augmentation and tolerance with longterm pramipexole treatment of restless legs syndrome (RLS)", Sleep Med, 5, pp.9~14 (2004)
- Montplaisir J, "Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial", Mov Disord, 21, pp.1627~1635 (2006)
- Allen RP, "Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample", Sleep Med, 12, pp.431~439 (2011)
- Allen RP, "Augmentation of the restless legs syndrome with carbidopa", levodopa, 1996, pp.19, 205~213
- Allen RP, "Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial", Sleep Med, 12, pp.906~913 (2011)
- Manconi M, "Dissociation of periodic leg movements from arousals in restless legs syndrome", Ann Neurol, 71, pp.834~844 (2012)